Verastem Announces Publication of Data for VS-5584 in Molecular Cancer Therapeutics
Posted on February 06, 2013 at 07:22 AM EST
Verastem, Inc., (NASDAQ: VSTM ), a clinical-stage biopharmaceutical company focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced the publication of